Drug profile · INN
eflornithine hydrochloride
ORNIDYL
eflornithine hydrochloride (ORNIDYL) is a ornithine decarboxylase inhibitor. Route of administration: topical. Current US regulatory status: approved.
Drug details — eflornithine hydrochloride
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
eflornithine hydrochloride (ORNIDYL) is a ornithine decarboxylase inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Ornithine decarboxylase inhibitor
Primary target: Ornithine decarboxylase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is eflornithine hydrochloride?
eflornithine hydrochloride (ORNIDYL) is a ornithine decarboxylase inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for eflornithine hydrochloride?
ORNIDYL is a marketed brand name for eflornithine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of eflornithine hydrochloride?
eflornithine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.